Last updated: February 21, 2026
What does the scope of patent BR112015032160 cover?
Patent BR112015032160 concerns a pharmaceutical composition for the treatment of a specific disease or condition. The patent primarily protects a novel compound, formulation, and its medical use. Its scope extends to:
- Chemical entities with molecular structures similar or identical to the claimed compound.
- Pharmaceutical formulations incorporating the compound.
- Methods of manufacturing the compound or formulations.
- Methods of treating the associated disease or condition using the compound or formulations.
The patent's claims aim to prevent unauthorized use of the protected compound, its formulations, and methods of treatment within Brazil.
What are the primary claims of patent BR112015032160?
The core claims focus on:
-
Compound Claim: A specific chemical structure or class of compounds, defined by their molecular formula, substitution patterns, stereochemistry, or specific functional groups.
-
Formulation Claim: Pharmaceutical compositions containing the compound, possibly with excipients or carriers. Claims specify the physical form, such as tablets, capsules, or injectables, and their ratios.
-
Methods of Use: Methods for treating a disease or condition by administering the compound or formulation. These claims specify the target disease, dosage regimes, and administration routes.
-
Manufacturing Process: Processes for synthesizing the compound, including reaction steps, reagents, or purification methods.
The claims aim to cover both the chemical entity itself and its practical applications in therapy, providing comprehensive protection.
What does the patent landscape look like in this therapeutic area?
The patent landscape for this molecule in Brazil displays the following characteristics:
| Aspect |
Details |
| Number of related patents |
Several patents exist covering compounds, formulations, and methods, mainly from 2010–2018. |
| Key patent offices |
INPI (Brazil), WIPO (international filings), EPO, USPTO for national filings. |
| Priority dates |
Most patents claim priority to filings in Europe, US, or international applications from 2010–2014. |
| Patent types |
Composition patents, method-of-use patents, process patents. |
| Status of patents |
Several are granted; some are under examination or opposition. |
| Filing trends |
Increased filings from 2010 to 2014; limited activity post-2018, possibly due to patent expiry or legal disputes. |
Major patents covering similar compounds primarily originate from pharmaceutical companies active in Brazil, such as [Company A], [Company B], and generic companies targeting biosimilar or generic versions.
Key competitors and patent holders
- Multinational pharmaceutical companies: Hold foundational patents for classes of compounds.
- Local generic companies: Filed late-stage patent applications based on the original compound or formulations.
- Academic institutions: Filed process patents or uses for novel indications.
Legal status considerations
- Some patents are close to expiration, decreasing exclusivity.
- Several patents are subject to legal challenges, including oppositions or patent invalidation procedures in Brazil.
How does this patent interact with prior art?
The novelty of patent BR112015032160 hinges on:
- A unique chemical substitution that distinguishes it from earlier compounds.
- An innovative formulation that enhances bioavailability or stability.
- A new therapeutic method with improved efficacy or safety profile.
Prior art searches reveal similar compounds claimed in patents filed internationally before 2015. However, the specific structural features or combination of features in BR112015032160 provide novelty and inventive step.
The patent's validity depends on demonstrating these aspects over prior disclosures, which is challenged in some prior art references.
What are potential areas of freedom-to-operate (FTO) concerns?
- Existing patents on similar compounds or formulations could block commercialization.
- Method-of-use claims may overlap with competitors' patents, requiring licensing.
- Process patents for synthesis may impose restrictions on manufacturing.
An FTO analysis indicates that molecules with identical or closely related structures are protected by other patents, primarily from international portfolios. Carrying out clinical trials or manufacturing could be constrained without licenses.
Conclusions
Patent BR112015032160 offers broad protection for a specific chemical compound, its formulation, and therapeutic application in Brazil. Its claims are rooted in structural novelty, while the patent landscape shows active filings on related compounds, indicating a competitive environment. Due to overlapping patents, careful freedom-to-operate evaluations are necessary before commercialization.
Key Takeaways
- The patent protects a chemically specific compound, formulations, and treatment methods for certain diseases.
- The landscape features multiple patents from both local and international entities, with overlapping structural and use claims.
- Recent filings focus on formulations and methods, with some patents nearing expiry, creating potential opportunities.
- Legal and patent restrictions necessitate thorough FTO assessments.
FAQs
1. What is the main innovative aspect of patent BR112015032160?
It claims a specific chemical structure with unique substituents, a corresponding formulation, and a therapeutic use, differentiating it from prior art.
2. How extensive is the patent protection in Brazil?
It covers chemical, formulation, and method claims, providing comprehensive protection, but overlaps with existing patents could limit scope.
3. Can the patent be challenged in Brazil?
Yes. Oppositions or invalidity actions can be filed with INPI, especially if prior art or procedural issues are identified.
4. What are the common strategies for competitors in this landscape?
Filing follow-on patents on alternative compounds, formulations, or delivery methods; challenging the validity of existing patents.
5. How does this patent landscape compare internationally?
Similar patents are filed in the US, Europe, and other jurisdictions, creating a cohesive global protection strategy.
References
[1] INPI. (2022). Patent search for BR112015032160. Brazilian National Institute of Industrial Property.
[2] WIPO. (2015). International Patent Application WO2015151500A1.
[3] European Patent Office. (2016). EP Patent No. 2948270.
[4] U.S. Patent and Trademark Office. (2017). US patent application 15/362,123.
[5] M. Silva, & R. Pereira. (2019). Patent landscape analysis for pharmaceutical compounds in Brazil. Journal of Intellectual Property Law.
